Medications like Mounjaro (tirzepatide) and Ozempic (semaglutide) mimic or enhance these effects, resulting in: Decreased appetite Reduced cravings Longer-lasting satiety after meals More stable blood sugar levels Over time, this leads to consistent weight loss , without the stress of crash dieting or extreme workouts
One hypothesis is that chronic GIP receptor agonism desensitizes the GIP receptor, creating an antagonism, which ultimately leads to weight loss
The cost implications add up over a multi-month protocol
Originally developed and FDA-approved for managing type 2 diabetes, Ozempic belongs to a group of medications known as GLP-1 receptor agonists
Compounded semaglutide is a synthetic analoga modified version that binds to the same cellular receptors but lasts for nearly a week, providing sustained appetite and blood-sugar control
Some programs offer access to branded GLP-1 medications that are injectable, as well as personalized oral medication kits that may include ingredients like metformin, bupropion, topiramate, vitamin B12, or naltrexone
